Year None20232022202120202019201820172016 September 6, 2023 Medicenna to Participate at The H.C. Wainwright 25th Annual Global Investment Conference Go to August 28, 2023 Medicenna Announces the Appointment of Jeff Caravella as Chief Financial Officer Go to August 14, 2023 Medicenna Establishes Boston Presence, Appoints Brent Meadows as Chief Business Officer, and Bolsters Management Go to August 9, 2023 Medicenna Completes MDNA11 Dose Escalation and Commences Monotherapy Dose Expansion in the Phase 1/2 ABILITY Study Go to August 8, 2023 Medicenna Appoints Dr. Arash Yavari as Chair of Development Advisory Committee Go to August 4, 2023 Medicenna Therapeutics to Provide Clinical Update from Phase 1/2 ABILITY Study on August 9, 2023 Go to Pagination Current page 1 Page 2 Page 3 Page 4 Next page next › Last page last »
September 6, 2023 Medicenna to Participate at The H.C. Wainwright 25th Annual Global Investment Conference Go to
August 28, 2023 Medicenna Announces the Appointment of Jeff Caravella as Chief Financial Officer Go to
August 14, 2023 Medicenna Establishes Boston Presence, Appoints Brent Meadows as Chief Business Officer, and Bolsters Management Go to
August 9, 2023 Medicenna Completes MDNA11 Dose Escalation and Commences Monotherapy Dose Expansion in the Phase 1/2 ABILITY Study Go to
August 4, 2023 Medicenna Therapeutics to Provide Clinical Update from Phase 1/2 ABILITY Study on August 9, 2023 Go to
